Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$696M |
| 2 |
AABA
Altaba Inc
AABA
|
+$632M |
| 3 |
AT&T
T
|
+$433M |
| 4 |
Goldman Sachs
GS
|
+$392M |
| 5 |
Walt Disney
DIS
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$938M |
| 5 |
Netflix
NFLX
|
+$423M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.29% |
| 2 | Technology | 1.9% |
| 3 | Financials | 1.28% |
| 4 | Communication Services | 1.02% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
3801
PUT
DELISTED
NEVRO CORP.
NVRO
| $2.23M | ﹤0.01% |
27,900
+21,200
| +316% | +$1.76M |
|
3802
Neurocrine Biosciences
NBIX
$15.7B
| $2.23M | ﹤0.01% |
+22,646
| New | +$2.03M |
|
3803
CALL
Gartner
IT
$12.5B
| $2.22M | ﹤0.01% |
16,700
+15,000
| +882% | +$1.92M |
|
3804
CALL
Banco Macro
BMA
$4.86B
| $2.22M | ﹤0.01% |
37,700
+9,700
| +35% | +$833K |
|
|
AIMC
3805
CALL
DELISTED
Altra Industrial Motion Corp
AIMC
| $2.21M | ﹤0.01% |
51,400
+34,400
| +202% | +$1.5M |
|
3806
PUT
Monro
MNRO
$405M
| $2.21M | ﹤0.01% |
38,100
+8,000
| +27% | +$452K |
|
3807
CALL
Travel + Leisure Co
TNL
$4.36B
| $2.21M | ﹤0.01% |
50,000
-291,553
| -85% | -$14.4M |
|
|
ALDR
3808
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.21M | ﹤0.01% |
140,071
+113,373
| +425% | +$1.72M |
|
3809
Popular Inc
BPOP
$10.8B
| $2.21M | ﹤0.01% |
48,885
-38,750
| -44% | -$1.77M |
|
|
TCF
3810
DELISTED
TCF Financial Corporation Common Stock
TCF
| $2.21M | ﹤0.01% |
+39,692
| New | +$2.24M |
|
|
BRFS
3811
DELISTED
BRF SA
BRFS
| $2.21M | ﹤0.01% |
471,934
+404,522
| +600% | +$2.54M |
|
3812
PUT
Geron
GERN
$970M
| $2.21M | ﹤0.01% |
643,900
+281,300
| +78% | +$1.07M |
|
3813
CALL
PRA Group
PRAA
$721M
| $2.21M | ﹤0.01% |
57,300
+33,400
| +140% | +$1.29M |
|
3814
CALL
Brookfield Infrastructure Partners
BIP
$17.5B
| $2.21M | ﹤0.01% |
96,600
+66,360
| +219% | +$1.56M |
|
3815
VanEck Oil Services ETF
OIH
$1.99B
| $2.21M | ﹤0.01% |
4,201
-2,813
| -40% | -$1.51M |
|
|
GMLP
3816
DELISTED
Golar LNG Partners LP
GMLP
| $2.21M | ﹤0.01% |
142,783
+63,569
| +80% | +$1.15M |
|
|
ITCI
3817
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.21M | ﹤0.01% |
124,826
-26,578
| -18% | -$540K |
|
3818
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
| $2.21M | ﹤0.01% |
33,012
-67,092
| -67% | -$4.39M |
|
|
AIMT
3819
PUT
DELISTED
Aimmune Therapeutics
AIMT
| $2.2M | ﹤0.01% |
81,900
-308,600
| -79% | -$9.44M |
|
|
HRC
3820
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.2M | ﹤0.01% |
25,200
+11,300
| +81% | +$1M |
|
|
VISN
3821
CALL
Vistance Networks Inc
VISN
$1.4B
| $2.2M | ﹤0.01% |
75,300
+31,700
| +73% | +$1.04M |
|
3822
Huazhu Hotels Group
HTHT
$14.7B
| $2.2M | ﹤0.01% |
+52,365
| New | +$2.09M |
|
3823
CALL
iShares Expanded Tech Sector ETF
IGM
$10.6B
| $2.2M | ﹤0.01% |
68,400
-145,200
| -68% | -$4.58M |
|
3824
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
| $2.2M | ﹤0.01% |
87,529
+7,402
| +9% | +$186K |
|
3825
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65.1M
| $2.2M | ﹤0.01% |
17,165
+14,800
| +626% | +$1.95M |
|
Similar funds
Jeff Yass's Q2 2018 Portfolio in Review
As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Financials.
- Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
- Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
- Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
- Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
- Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
- Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.